Лучшие больницы для «Coronary Angiography» в ОАЭ

Coronary angiography is substantially more affordable in India compared to the UAE and both are significantly cheaper than Western countries. In India, a diagnostic coronary angiography (catheterization-only, no stenting) at a NABH- or JCI-accredited hospital typically costs between USD 600 and USD 1,800 — inclusive of catheterization laboratory fees, contrast agents, standard medication during the procedure, and one night of monitored hospital stay. In the UAE (Dubai or Abu Dhabi) at JCI- and DHA-accredited centres such as Cleveland Clinic Abu Dhabi or American Hospital Dubai, the same procedure ranges from approximately USD 1,800 to USD 4,500, reflecting the premium private healthcare environment, higher facility overheads, and imported consumable costs. By comparison, the same procedure in the United States typically costs USD 10,000–USD 20,000 or more. It is critical to note that these figures cover diagnostic angiography only. If percutaneous coronary intervention (PCI) — including drug-eluting stent implantation, fractional flow reserve assessment (FFR), or intravascular imaging (IVUS/OCT) — is performed in the same session, additional costs apply and will be transparently quoted by GAF Healthcare prior to your departure. GAF Healthcare provides fixed pre-authorised cost packages with zero hidden billing, and our case managers can obtain a written cost estimate within 48 hours of receiving your medical records.

The duration of in-country stay after coronary angiography depends on whether the procedure was purely diagnostic or whether percutaneous coronary intervention (PCI) was performed in the same session. For diagnostic angiography only (no stenting): The vast majority of patients are discharged within 24 hours. Provided the access site (radial or femoral) is well-healed and renal function is stable (contrast-induced nephropathy is typically monitored at 48 hours), patients are generally cleared to fly for short-haul journeys (under 4 hours) after 48–72 hours and for long-haul intercontinental flights after 5–7 days. For angiography with ad-hoc PCI (stent implantation): A minimum in-country stay of 5–7 days is recommended for short-haul travel and 10–14 days for long-haul intercontinental flights. This allows monitoring for early stent-related complications (peri-procedural myocardial infarction, acute stent thrombosis), confirmation of dual antiplatelet therapy (DAPT — aspirin + clopidogrel or ticagrelor) tolerability, and stabilisation of renal function. Your treating interventional cardiologist at the GAF Healthcare partner hospital will issue an official medical fitness-to-fly certificate at discharge, taking into account your specific clinical profile, access-site healing, post-procedure troponin trends, and any comorbidities. Patients with eGFR <45 mL/min/1.73m² or those who experienced any peri-procedural complication may require a longer stay for additional monitoring.

Coronary angiography has an exceptionally high procedural success rate and an outstanding safety profile when performed at accredited, high-volume interventional cardiology centres. The diagnostic success rate — defined as the ability to fully visualize all major epicardial coronary arteries and their significant branches with diagnostic-quality imaging — exceeds 95–98% in experienced centres. Technical failure is rare and is most commonly attributable to extreme coronary tortuosity, ostial anomalies, or severe peripheral vascular disease limiting arterial access. The major adverse event rate — encompassing death, stroke, myocardial infarction, or emergency surgery attributable to the angiography procedure itself — is less than 0.1% (fewer than 1 in 1,000 procedures) in NABH- and JCI-accredited hospitals in India and DHA-licensed centres in the UAE. Minor complications (access-site haematoma, contrast-induced nephropathy, vasovagal reaction) occur in 1–5% of cases and are almost universally self-limiting. When adjunctive techniques such as Fractional Flow Reserve (FFR), intravascular ultrasound (IVUS), or Optical Coherence Tomography (OCT) are used to guide any concurrent PCI, the clinical success rate of stent implantation (defined as residual stenosis <10%, TIMI-3 flow, and absence of major procedural complications) exceeds 97% in contemporary practice. These outcomes are consistent with benchmarked international data from the NCDR Cath-PCI Registry, the British Cardiovascular Intervention Society (BCIS) audit, and the EuroCathNet registry.